BRPI0802298A2 - processo de tratamento de um implante e implante à base de protéina tratado - Google Patents

processo de tratamento de um implante e implante à base de protéina tratado

Info

Publication number
BRPI0802298A2
BRPI0802298A2 BRPI0802298-4A BRPI0802298A BRPI0802298A2 BR PI0802298 A2 BRPI0802298 A2 BR PI0802298A2 BR PI0802298 A BRPI0802298 A BR PI0802298A BR PI0802298 A2 BRPI0802298 A2 BR PI0802298A2
Authority
BR
Brazil
Prior art keywords
implant
protein
treated
treating
substrate
Prior art date
Application number
BRPI0802298-4A
Other languages
English (en)
Inventor
Shen Ming
Original Assignee
Perouse Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Perouse Lab filed Critical Perouse Lab
Publication of BRPI0802298A2 publication Critical patent/BRPI0802298A2/pt
Publication of BRPI0802298B1 publication Critical patent/BRPI0802298B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A61L27/3625—Vascular tissue, e.g. heart valves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3641—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the site of application in the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3641—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the site of application in the body
    • A61L27/3645—Connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3687—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Molecular Biology (AREA)
  • Vascular Medicine (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Peptides Or Proteins (AREA)

Abstract

PROCESSO DE TRATAMENTO DE UM IMPLANTE E IMPLANTE à BASE DE PROTEìNA TRATADO. A presente invenção refere-se a um processo de tratamento de um implante que comporta um substrato à base de proteínas, que compreende as etapas em que: (A) O substrato à base de proteínas é tratado com um composto portador de pelo menos um grupo aldeido, e a seguir (B) O substrato é tratado com um composto que compreende um boroidreto, e a seguir (C) O substrato proveniente da etapa (B) é tratado com um derivado portador de um grupo silano. A presente invenção refere-se também ao implante á base de proteínas obtido no final desse processo.
BRPI0802298-4A 2007-06-20 2008-06-20 Processo de tratamento de um implante BRPI0802298B1 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0755890 2007-06-20
FR0755890A FR2917625B1 (fr) 2007-06-20 2007-06-20 Traitement de dispositifs medicaux implantables resistants a la calcification

Publications (2)

Publication Number Publication Date
BRPI0802298A2 true BRPI0802298A2 (pt) 2009-03-31
BRPI0802298B1 BRPI0802298B1 (pt) 2018-06-19

Family

ID=38988380

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0802298-4A BRPI0802298B1 (pt) 2007-06-20 2008-06-20 Processo de tratamento de um implante

Country Status (7)

Country Link
US (1) US20080319166A1 (pt)
EP (1) EP2005977B1 (pt)
JP (1) JP5265253B2 (pt)
CN (1) CN101337088B (pt)
BR (1) BRPI0802298B1 (pt)
DE (1) DE602008000403D1 (pt)
FR (1) FR2917625B1 (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9101691B2 (en) 2007-06-11 2015-08-11 Edwards Lifesciences Corporation Methods for pre-stressing and capping bioprosthetic tissue
US8357387B2 (en) 2007-12-21 2013-01-22 Edwards Lifesciences Corporation Capping bioprosthetic tissue to reduce calcification
US8906601B2 (en) 2010-06-17 2014-12-09 Edwardss Lifesciences Corporation Methods for stabilizing a bioprosthetic tissue by chemical modification of antigenic carbohydrates
CN102946916B (zh) 2010-06-17 2015-03-18 爱德华兹生命科学公司 通过化学修饰抗原性碳水化合物稳定生物假体组织的方法
US9351829B2 (en) * 2010-11-17 2016-05-31 Edwards Lifesciences Corporation Double cross-linkage process to enhance post-implantation bioprosthetic tissue durability
US9615922B2 (en) 2013-09-30 2017-04-11 Edwards Lifesciences Corporation Method and apparatus for preparing a contoured biological tissue
US10959839B2 (en) 2013-10-08 2021-03-30 Edwards Lifesciences Corporation Method for directing cellular migration patterns on a biological tissue
GB2556616B (en) 2016-07-21 2019-09-25 Cipher Surgical Ltd Scope assembly
CN110678590B (zh) 2017-05-31 2022-07-19 爱德华兹生命科学公司 胶原纤维和由其形成的制品
AU2019212059A1 (en) 2018-01-23 2020-05-21 Edwards Lifesciences Corporation Method for pre-stretching implantable biocompatible materials, and materials and devices produced thereby
US11103619B2 (en) 2018-08-30 2021-08-31 Efstathios-Andreas AGATHOS Anticalcification treatment for impantable biological tissues using calcitonin
CN113164258B (zh) 2018-11-01 2024-08-27 爱德华兹生命科学公司 经导管再生肺动脉瓣
CN110025403B (zh) * 2019-04-11 2020-09-15 宁波健世生物科技有限公司 一种通过涂层的方式改善人工生物瓣膜钙化的方法
CA3143206A1 (en) 2019-12-09 2021-06-17 Edwards Lifesciences Corporation Bioprosthetic tissue preparation
CN110917398A (zh) * 2019-12-09 2020-03-27 沛嘉医疗科技(苏州)有限公司 生物材料的抗氧化方法及生物材料

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4553974A (en) * 1984-08-14 1985-11-19 Mayo Foundation Treatment of collagenous tissue with glutaraldehyde and aminodiphosphonate calcification inhibitor
US5509932A (en) * 1993-04-08 1996-04-23 Keogh; James R. Fixed tissue medical devices comprising albumin-binding dyes
US5645587A (en) * 1996-06-05 1997-07-08 Chanda; Jyotirmay Prevention of calcification and degeneration of biological tissue grafts for implantation in humans
US5862806A (en) * 1997-10-30 1999-01-26 Mitroflow International, Inc. Borohydride reduction of biological tissues
CN1147323C (zh) * 2000-05-09 2004-04-28 天津大学 壳聚糖/明胶网络支架材料
US8097269B2 (en) * 2004-02-18 2012-01-17 Celonova Biosciences, Inc. Bioactive material delivery systems comprising sol-gel compositions
US7422607B2 (en) * 2004-08-24 2008-09-09 Oviatt Henry W Anti-calcification treatments for heart valves and vascular grafts
US7579381B2 (en) * 2005-03-25 2009-08-25 Edwards Lifesciences Corporation Treatment of bioprosthetic tissues to mitigate post implantation calcification

Also Published As

Publication number Publication date
FR2917625B1 (fr) 2009-09-18
JP5265253B2 (ja) 2013-08-14
DE602008000403D1 (de) 2010-01-28
EP2005977A1 (fr) 2008-12-24
JP2009006142A (ja) 2009-01-15
FR2917625A1 (fr) 2008-12-26
US20080319166A1 (en) 2008-12-25
CN101337088B (zh) 2013-04-24
EP2005977B1 (fr) 2009-12-16
BRPI0802298B1 (pt) 2018-06-19
CN101337088A (zh) 2009-01-07

Similar Documents

Publication Publication Date Title
WO2005104259A3 (de) Verkapselung für ein organisches elekronisches bauteil, herstellungsverfahren dazu, sowie verwendung
TW200951672A (en) System and method for modifying a data set of a photomask
BRPI0706333A2 (pt) processo de tratamento das fibras queratÍnicas humanas
WO2004047144A3 (de) Organisches elektronisches bauelement mit stukturierter halbleitender funktionsschicht und herstellungsverfahren dazu
BRPI0519496A2 (pt) processo para preparar um composto ou uma composiÇço, e, composiÇço
WO2006089540A3 (de) Verfahren zur herstellung eines optischen und eines strahlungsemittierenden bauelementes und optisches sowie strahlunsemittierendes bauelement
WO2005083812A3 (de) Verfahren zur vernetzung organischer halbleiter
WO2009089001A3 (en) Direct-to-metal radiation curable compositions
SG136030A1 (en) Method for manufacturing compound material wafers and method for recycling a used donor substrate
DE60333149D1 (de) Verfahren zur Herstellung von organischen elektrolumineszenten Vorrichtungen
WO2007001803A3 (en) Cure catalyst, composition, electronic device and associated method
BR112013006118A2 (pt) composição aquosa de revestimento e método para prevenção de oxidação usando a composição de revestimento aquoso
DE60330543D1 (de) Verfahren zur abscheidung anorganischer/organischer filme
BR0312040B1 (pt) método de oxidação de um composto orgánico presente no solo, em águas subterráneas, águas de processo ou residuais.
ATE541569T1 (de) Verfahren zur isolation von phenolischen verbindungen
WO2009152211A3 (en) Initiator system with biphenylene derivates, method of production and use thereof
DK2032739T3 (da) Fremgangmåde til coating af skiver og coatet skive til låsning
ATE549361T1 (de) Verfahren zur korrelierung von uv-vis-spektren einer norbonenverbindung, polymerisierungsverfahren damit sowie entsprechende reinigungsverfahren und - zusammensetzungen
BRPI0717204A2 (pt) processo sde produÇço de 4-benzilideno-2,6-di-terc-butilciclo-hexa-2,5-dienona
BRPI0509363A (pt) método para aumentar a eficácia preservativa de uma composição, composição oftálmica, método de tratamento de uma condição oftálmica e processo para produzir uma composição oftálmica
BRPI0923780A2 (pt) Processo para preparar composto, processo para decomposição do composto, composto, composição, método para tratar câncer, e, pelo menos um quilograma de composto
DE60331043D1 (de) Verfahren zur entfernung von dithiogruppen aus polymerkettenenden
BRPI0907506A2 (pt) processo e dispositivo para remoção ao menos parcial de um revestimento bem com instalação d tratamento de superfície
TW200502076A (en) Method of manufacturing a replica, as well as a replica obtained by carrying out a uv light-initiated or thermal curing treatment of a reactive mixture
WO2006065561A3 (en) A composition, method of authenticating, methods of making authenticatable compositions, authenticatable articles made there from

Legal Events

Date Code Title Description
B03A Publication of a patent application or of a certificate of addition of invention [chapter 3.1 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B25A Requested transfer of rights approved

Owner name: PEROUSE MEDICAL (FR)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B25A Requested transfer of rights approved

Owner name: CORMOVE (FR)

B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]
B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 15A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2727 DE 11-04-2023 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.